Advertisement
Advertisement
TSHA
Taysha Gene Therapies, Inc. Common Stock
4.67
USDSponsored
-0.12
-2.51%
Sep 25, 15:59 UTC -4
Closed
After-Market
4.79
+0.13
+2.68%
Taysha Gene Therapies, Inc. Common Stock Financial Snapshot
| Market Cap | 1.56B |
| Beta | 1.19 |
| Earnings Per Share (EPS) | -0.42 |
| Price-to-Book (P/B) Ratio | 3.83 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 12.72% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -56.19% |
| Current Ratio | 17.76% |
| Free Cash Flow | -81.33M |
